Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Heregulin-induced AKT activation promotes growth of gefitinib ('Iressa', ZD1839)-treated, tamoxifen-resistant breast cancer cells [Abstract]

Hutcheson, Iain Robert, Knowlden, Janice Mary, Barrow, Denise, Gee, Julia Margaret Wendy, Robertson, J. F., Wakeling, A. E. and Nicholson, Robert Ian 2003. Heregulin-induced AKT activation promotes growth of gefitinib ('Iressa', ZD1839)-treated, tamoxifen-resistant breast cancer cells [Abstract]. Breast Cancer Research and Treatment 82 (S1) , S170. 10.1023/A:1026252325164

Full text not available from this repository.
Item Type: Article
Date Type: Publication
Status: Published
Schools: Pharmacy
Medicine
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RM Therapeutics. Pharmacology
Additional Information: Abstract for 26th Annual San Antonio Breast Cancer Symposium
Publisher: Springer Verlag
ISSN: 0167-6806
Last Modified: 05 Aug 2018 02:13
URI: http://orca-mwe.cf.ac.uk/id/eprint/17187

Actions (repository staff only)

Edit Item Edit Item